Carcinoma, Intraductal, Noninfiltrating
-
Subject Areas on Research
-
"Is it cancer or not?" A qualitative exploration of survivor concerns surrounding the diagnosis and treatment of ductal carcinoma in situ.
-
A multi-modal exploration of heterogeneous physico-chemical properties of DCIS breast microcalcifications.
-
A web-based personalized decision support tool for patients diagnosed with ductal carcinoma in situ: development, content evaluation, and usability testing.
-
Abbreviated screening protocol for breast MRI: a feasibility study.
-
Active Surveillance for DCIS: The Importance of Selection Criteria and Monitoring.
-
Altered lymphocyte populations in tumour invaded nodes of breast cancer patients.
-
Applying the neoadjuvant paradigm to ductal carcinoma in situ.
-
Array-based comparative genomic hybridization of ductal carcinoma in situ and synchronous invasive lobular cancer.
-
Assessing the Effect of Lifetime Contralateral Breast Cancer Risk on the Selection of Contralateral Prophylactic Mastectomy for Unilateral Breast Cancer.
-
Association between breast density and subsequent breast cancer following treatment for ductal carcinoma in situ.
-
Atypical ductal hyperplasia: improved accuracy with the 11-gauge vacuum-assisted versus the 14-gauge core biopsy needle.
-
Breast cancer: noninvasive and special situations.
-
Breast carcinoma, thyroid carcinoma, and T3 thyrotoxicosis in a male cretin.
-
Can Occult Invasive Disease in Ductal Carcinoma In Situ Be Predicted Using Computer-extracted Mammographic Features?
-
Can algorithmically assessed MRI features predict which patients with a preoperative diagnosis of ductal carcinoma in situ are upstaged to invasive breast cancer?
-
Cancer Outcomes in DCIS Patients Without Locoregional Treatment.
-
Cell-extrinsic consequences of epithelial stress: activation of protumorigenic tissue phenotypes.
-
Characterizing the impact of 25 years of DCIS treatment.
-
Classification of ipsilateral breast tumor recurrences after breast conservation therapy can predict patient prognosis and facilitate treatment planning.
-
Clinical Utility of the 12-Gene DCIS Score Assay: Impact on Radiotherapy Recommendations for Patients with Ductal Carcinoma In Situ.
-
Comparison of Reconstructive Outcomes in Breast Cancer Patients With Preexisting Subpectoral Implants: Implant-Sparing Mastectomy With Delayed Implant Exchange Versus Immediate Tissue Expander Reconstruction.
-
Current Trends in the Management of Ductal Carcinoma In Situ.
-
DCIS with Microinvasion: Is It In Situ or Invasive Disease?
-
De-Escalating Breast Cancer Surgery for Low-Risk Ductal Carcinoma in Situ.
-
De-Escalation of Locoregional Therapy in Low-Risk Disease for DCIS and Early-Stage Invasive Cancer.
-
Differential copy number aberrations in novel candidate genes associated with progression from in situ to invasive ductal carcinoma of the breast.
-
Do Histopathology and Clinical Outcomes of Breast Atypia Vary by Race/Ethnicity?
-
Ductal Carcinoma In Situ Biology, Language, and Active Surveillance: A Survey of Breast Radiologists' Knowledge and Opinions.
-
Ductal carcinoma in situ (DCIS): posttreatment follow-up care among Latina and non-Latina White women.
-
Ductal carcinoma in situ in BRCA mutation carriers.
-
Ductal carcinoma in situ: a review of recent advances.
-
Ductal carcinoma in situ: atypical mammographic appearances.
-
Ductal carcinoma in situ: knowledge of associated risks and prognosis among Latina and non-Latina white women.
-
Ductal carcinoma in situ: to treat or not to treat, that is the question.
-
Ductal epithelial proliferations of the breast: a biological continuum? Comparative genomic hybridization and high-molecular-weight cytokeratin expression patterns.
-
Early Adoption of the SSO-ASTRO Consensus Guidelines on Margins for Breast-Conserving Surgery with Whole-Breast Irradiation in Stage I and II Invasive Breast Cancer: Initial Experience from Memorial Sloan Kettering Cancer Center.
-
Estimating the magnitude of clinical benefit of local therapy in patients with DCIS.
-
Evaluation of Pathologic Nipple Discharge: What is the Added Diagnostic Value of MRI?
-
Evaluation of a breast cancer nomogram for predicting risk of ipsilateral breast tumor recurrences in patients with ductal carcinoma in situ after local excision.
-
Evaluation of new anticancer agents against human pancreatic carcinomas in nude mice.
-
Expression profiling of in vivo ductal carcinoma in situ progression models identified B cell lymphoma-9 as a molecular driver of breast cancer invasion.
-
FOXP3-positive regulatory T lymphocytes and epithelial FOXP3 expression in synchronous normal, ductal carcinoma in situ, and invasive cancer of the breast.
-
Features of occult invasion in biopsy-proven DCIS at breast MRI.
-
Flow cytometric analysis of cell surface carbohydrates in metastatic human breast cancer.
-
Flow cytometric analysis of comedocarcinoma of the prostate: an uncommon histopathological variant of prostatic adenocarcinoma.
-
Fluvastatin reduces proliferation and increases apoptosis in women with high grade breast cancer.
-
Functional CD3+CD8+PD1- T Cell Accumulation and PD-L1 Expression Increases During Tumor Invasion in DCIS of the Breast.
-
Growth Dynamics of Mammographic Calcifications: Differentiating Ductal Carcinoma in Situ from Benign Breast Disease.
-
HIN-1, a putative cytokine highly expressed in normal but not cancerous mammary epithelial cells.
-
Hepatic Resection or Ablation for Isolated Breast Cancer Liver Metastasis: A Case-control Study With Comparison to Medically Treated Patients.
-
Histological assessment of breast lesions identified exclusively by magnetic resonance.
-
How Low Can We Go-and Should We? Risk Reduction for Minimal-Volume DCIS.
-
Human breast cancer invasion and aggression correlates with ECM stiffening and immune cell infiltration.
-
Human breast cancer specimens: diffraction-enhanced imaging with histologic correlation--improved conspicuity of lesion detail compared with digital radiography.
-
Hypermethylation of 14-3-3 sigma (stratifin) is an early event in breast cancer.
-
Imaging Features of Patients Undergoing Active Surveillance for Ductal Carcinoma in Situ.
-
Immunoglobulin localization in benign and malignant lesions of the human mammary gland.
-
Impact of ductal carcinoma in situ terminology on patient treatment preferences.
-
Incidence of Adjacent Synchronous Invasive Carcinoma and/or Ductal Carcinoma In-situ in Patients with Lobular Neoplasia on Core Biopsy: Results from a Prospective Multi-Institutional Registry (TBCRC 020).
-
Incidence of Ductal Carcinoma In Situ in the United States, 2000-2014.
-
Incidence of autoimmune disease in patients after breast reconstruction with silicone gel implants versus autogenous tissue: a preliminary report.
-
Increased sectioning of pathologic specimens with ductal carcinoma in situ of the breast: are there clinical consequences?
-
Information exchange and decision making in the treatment of Latina and white women with ductal carcinoma in situ.
-
Is Bigger Better?: The Effect of Hospital Consolidation on Index Hospitalization Costs and Outcomes Among Privately Insured Recipients of Immediate Breast Reconstruction.
-
Lack of expression of androgen receptor may play a critical role in transformation from in situ to invasive basal subtype of high-grade ductal carcinoma of the breast.
-
Logical Differential Prediction Bayes Net, improving breast cancer diagnosis for older women.
-
Long-term risk of subsequent ipsilateral lesions after surgery with or without radiotherapy for ductal carcinoma in situ of the breast.
-
Loss of nuclear localized and tyrosine phosphorylated Stat5 in breast cancer predicts poor clinical outcome and increased risk of antiestrogen therapy failure.
-
Magnetic resonance imaging captures the biology of ductal carcinoma in situ.
-
Magnetic resonance imaging in patients diagnosed with ductal carcinoma-in-situ: value in the diagnosis of residual disease, occult invasion, and multicentricity.
-
Maintenance of DNA content and erbB-2 alterations in intraductal and invasive phases of mammary cancer.
-
Maintenance of p53 alterations throughout breast cancer progression.
-
Mammographic predictors of the presence and size of invasive carcinomas associated with malignant microcalcification lesions without a mass.
-
Metastatic lesions arising in a Riedel's lobe. Findings from a sulfur colloid liver-spleen scan.
-
Microtome shaving radiography: demonstration of loss of mammographic microcalcifications during histologic sectioning.
-
Mixed-Methods Study to Predict Upstaging of DCIS to Invasive Disease on Mammography.
-
Modeling the natural history of ductal carcinoma in situ based on population data.
-
Modified radical mastectomy with immediate reconstruction for carcinoma of the breast.
-
Molecular markers in ductal carcinoma in situ of the breast.
-
Molecular markers of therapeutic resistance in breast cancer.
-
Neoadjuvant hormonal therapy for ductal carcinoma in situ: trial design and preliminary results.
-
Nuclear Snail1 and nuclear ZEB1 protein expression in invasive and intraductal human breast carcinomas.
-
Oncologic Safety of Nipple-Sparing Mastectomy in Women with Breast Cancer.
-
Outcome of long term active surveillance for estrogen receptor-positive ductal carcinoma in situ.
-
Outcomes of Active Surveillance for Ductal Carcinoma in Situ: A Computational Risk Analysis.
-
Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast.
-
Papillary carcinoma of the breast: imaging findings.
-
Pathologic considerations in the high-risk breast patient.
-
Patient Preferences for Outcomes Following DCIS Management Strategies: A Discrete Choice Experiment.
-
Patterns of chromosomal alterations in breast ductal carcinoma in situ.
-
Phase II Single-Arm Study of Preoperative Letrozole for Estrogen Receptor-Positive Postmenopausal Ductal Carcinoma In Situ: CALGB 40903 (Alliance).
-
Plasma D-dimer levels in operable breast cancer patients correlate with clinical stage and axillary lymph node status.
-
Predicting Upstaging of DCIS to Invasive Disease: Radiologists's Predictive Performance.
-
Predicting a local recurrence after breast-conserving therapy by gene expression profiling.
-
Prediction of Occult Invasive Disease in Ductal Carcinoma in Situ Using Deep Learning Features.
-
Prediction of Upstaged Ductal Carcinoma In Situ Using Forced Labeling and Domain Adaptation.
-
Prediction of Upstaging in Ductal Carcinoma in Situ Based on Mammographic Radiomic Features.
-
Preoperative Single-Fraction Partial Breast Radiation Therapy: A Novel Phase 1, Dose-Escalation Protocol With Radiation Response Biomarkers.
-
Preoperative breast magnetic resonance imaging in early breast cancer: implications for partial breast irradiation.
-
Prioritization of research addressing management strategies for ductal carcinoma in situ.
-
Proliferation index in various stages of breast cancer determined by Ki-67 immunostaining.
-
Promoter polymorphism (-786t>C) in the endothelial nitric oxide synthase gene is associated with risk of sporadic breast cancer in non-Hispanic white women age younger than 55 years.
-
Protein acetylation and histone deacetylase expression associated with malignant breast cancer progression.
-
Pulmonary changes after primary irradiationfor early breast carcinoma.
-
Quality of Patient Decisions About Breast Reconstruction After Mastectomy.
-
Recurrence after mastectomy for ductal carcinoma in situ.
-
Recurrent ductal carcinoma in situ after total mastectomy.
-
Relationship between Background Parenchymal Enhancement on High-risk Screening MRI and Future Breast Cancer Risk.
-
Resection margins in carcinoma of the head of the pancreas. Implications for radiation therapy.
-
Response to Habel and Buist.
-
Risk of invasive breast cancer and ductal carcinoma in situ in women with atypical papillary lesions of the breast.
-
Role of Preoperative Variables in Reducing the Rate of Occult Invasive Disease for Women Considering Active Surveillance for Ductal Carcinoma In Situ.
-
Selection of treatment among Latina and non-Latina white women with ductal carcinoma in situ.
-
Should New "No Ink On Tumor" Lumpectomy Margin Guidelines be Applied to Ductal Carcinoma In Situ (DCIS)? A Retrospective Review Using Shaved Cavity Margins.
-
Society of Surgical Oncology-American Society for Radiation Oncology-American Society of Clinical Oncology Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Ductal Carcinoma In Situ.
-
Society of Surgical Oncology-American Society for Radiation Oncology-American Society of Clinical Oncology Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Ductal Carcinoma in Situ.
-
Society of Surgical Oncology-American Society for Radiation Oncology-American Society of Clinical Oncology Consensus Guideline on Margins for Breast-Conserving Surgery with Whole-Breast Irradiation in Ductal Carcinoma In Situ.
-
Sonographic detection and sonographically guided biopsy of breast microcalcifications.
-
Sonographically guided biopsy of suspicious microcalcifications of the breast: a pilot study.
-
Surgical Upstaging Rates for Vacuum Assisted Biopsy Proven DCIS: Implications for Active Surveillance Trials.
-
Suspicious breast calcifications undergoing stereotactic biopsy in women ages 70 and over: Breast cancer incidence by BI-RADS descriptors.
-
T cell receptor gamma/delta expression on lymphocyte populations of breast cancer patients.
-
The Incidence of Adjacent Synchronous Invasive Carcinoma and/or Ductal Carcinoma In Situ in Patients with Intraductal Papilloma without Atypia on Core Biopsy: Results from a Prospective Multi-Institutional Registry (TBCRC 034).
-
The Influence of Age on the Histopathology and Prognosis of Atypical Breast Lesions.
-
The current clinical value of the DCIS Score.
-
The effect of system-level access factors on receipt of reconstruction among Latina and white women with DCIS.
-
The effect of treatment on patient-reported distress after breast cancer diagnosis.
-
The impact of surgery on ductal carcinoma in situ outcomes: the use of mastectomy.
-
Transition to invasive breast cancer is associated with progressive changes in the structure and composition of tumor stroma.
-
Trends in Treatment Patterns and Outcomes for Ductal Carcinoma In Situ.
-
Tumor-associated antigen TAG-72: correlation of expression in primary and metastatic breast carcinoma lesions.
-
Updates on treating ductal carcinoma in situ: what's to know in 2021.
-
Validation of an oligo-gene signature for the prognostic stratification of ductal carcinoma in situ (DCIS).
-
Variability in diagnostic threshold for comedo necrosis among breast pathologists: implications for patient eligibility for active surveillance trials of ductal carcinoma in situ.
-
Variations in cancer care for adolescents and young adults (AYAs) with ductal carcinoma in situ.
-
Volume of resection in patients treated with breast conservation for ductal carcinoma in situ.
-
What Can Molecular Diagnostics Add to Locoregional Treatment Recommendations for DCIS?
-
Whole-breast radiation therapy: the long and short of it.